DAXX, as a Tumor Suppressor, Impacts DNA Damage Repair and Sensitizes BRCA-Proficient TNBC Cells to PARP Inhibitors
Open Access
Abstract
No abstract availableKeywords
Funding Information
- National Science Foundation of China (81773102, 81470357)
- Foundation for Clinical Medicine Science and Technology (BL2014071)
This publication has 30 references indexed in Scilit:
- Rad51 Promoter-Targeted Gene Therapy Is Effective for In Vivo Visualization and Treatment of CancerMolecular Therapy, 2012
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapiesJournal of Clinical Investigation, 2011
- Daxx mediates SUMO-dependent transcriptional control and subnuclear compartmentalizationBiochemical Society Transactions, 2007
- Regulation of c-met expression by transcription repressor DaxxOncogene, 2007
- Critical role for Daxx in regulating Mdm2Nature Cell Biology, 2006
- RAD51, genomic stability, and tumorigenesisCancer Letters, 2005
- Negative Modulation of Androgen Receptor Transcriptional Activity by DaxxMolecular and Cellular Biology, 2004
- Negative Regulation of p53 Functions by Daxx and the Involvement of MDM2Journal of Biological Chemistry, 2004
- The Transcriptional Repressor hDaxx Potentiates p53-dependent ApoptosisJournal of Biological Chemistry, 2004
- DNA damage tumor suppressor genes and genomic instabilityCurrent Opinion in Genetics & Development, 2004